Title | Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study |
Author | |
Corresponding Author | Wang,Lifei; Zhang,Chen |
Publication Years | 2022
|
DOI | |
Source Title | |
ISSN | 0938-7994
|
EISSN | 1432-1084
|
Volume | 33Issue:3Pages:1653-1667 |
Abstract | Objectives: To investigate the value of R2* mapping–based radiomics nomograms in staging liver fibrosis in patients with chronic hepatitis B. Methods: Between January 2020 and December 2020, 151 patients with chronic hepatitis B were randomly divided into training (n = 103) and validation (n = 48) cohorts. From January to February 2021, 58 patients were included in a test cohort. Radiomics features were selected using the interclass correlation coefficient and least absolute shrinkage and selection operator method. Three radiomics nomograms, combining the radiomics score (Radscore) derived from R2* mapping and clinical variables, were used for staging significant and advanced fibrosis, and cirrhosis. Performance of the model was evaluated using the AUC. The utility and clinical benefits were evaluated using the continuous net reclassification index (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA). Results: The Radscore calculated by 12 radiomics features and independent factors (laminin and platelet) of advanced fibrosis were used to construct the radiomics nomograms. In the test cohort, the AUCs of the radiomics nomograms for staging significant fibrosis, advanced fibrosis, and cirrhosis were 0.738 (95% confidence interval [CI]: 0.604–0.872), 0.879 (95% CI: 0.779–0.98), and 0.952 (95% CI: 0.878–1), respectively. NRI, IDI, and DCA confirmed that radiomics nomograms demonstrated varying degrees of clinical benefit and improvement for advanced fibrosis and cirrhosis, but not for significant fibrosis. Conclusions: Radiomics nomograms combined with R2* mapping–based Radscore, laminin, and platelet have value in staging advanced fibrosis and cirrhosis but limited value for staging significant fibrosis. Key Points: • Laminin and platelets were independent predictors of advanced fibrosis. • Radiomics analysis based on R2* mapping was beneficial for evaluating advanced fibrosis and cirrhosis. • It was difficult to distinguish significant fibrosis using a radiomics nomogram, which is possibly due to the complex pathological microenvironment of chronic liver diseases. |
Keywords | |
URL | [Source Record] |
Indexed By | |
Language | English
|
SUSTech Authorship | First
; Corresponding
|
WOS Research Area | Radiology, Nuclear Medicine & Medical Imaging
|
WOS Subject | Radiology, Nuclear Medicine & Medical Imaging
|
WOS Accession No | WOS:000859689100002
|
Publisher | |
ESI Research Field | CLINICAL MEDICINE
|
Scopus EID | 2-s2.0-85138732791
|
Data Source | Scopus
|
Citation statistics |
Cited Times [WOS]:0
|
Document Type | Journal Article |
Identifier | http://kc.sustech.edu.cn/handle/2SGJ60CL/402756 |
Department | School of Medicine 南方科技大学第二附属医院 |
Affiliation | 1.Department of Radiology,National Clinical Research Center for Infectious Disease,Shenzhen Third People’s Hospital,The Second Affiliated Hospital,School of Medicine Southern University of Science and Technology,Shenzhen,29 Bulan Road, Longgang District, Guangdong,518000,China 2.Department of Pathology,National Clinical Research Center for Infectious Disease,Shenzhen Third People’s Hospital,The Second Affiliated Hospital,School of Medicine Southern University of Science and Technology,Shenzhen,29 Bulan Road, Longgang District, Guangdong,518000,China |
First Author Affilication | School of Medicine; The Third People's Hospital of Shenzhen |
Corresponding Author Affilication | School of Medicine; The Third People's Hospital of Shenzhen |
First Author's First Affilication | School of Medicine; The Third People's Hospital of Shenzhen |
Recommended Citation GB/T 7714 |
Zhang,Die,Cao,Yi,Sun,Yi,et al. Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study[J]. EUROPEAN RADIOLOGY,2022,33(3):1653-1667.
|
APA |
Zhang,Die.,Cao,Yi.,Sun,Yi.,Zhao,Xia.,Peng,Cheng.,...&Zhang,Chen.(2022).Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study.EUROPEAN RADIOLOGY,33(3),1653-1667.
|
MLA |
Zhang,Die,et al."Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study".EUROPEAN RADIOLOGY 33.3(2022):1653-1667.
|
Files in This Item: | There are no files associated with this item. |
|
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment